PURPOSE: Significant dosimetric improvement for radiation therapy using optimized noncoplanar fields has been previously demonstrated. The purpose here is to study the feasibility of optimized robotic noncoplanar radiation therapy, termed 4π therapy, for prostate cancer treatments on a conventional C-arm linac. METHODS AND MATERIALS: Twelve low-risk prostate cancer patients previously treated by 2-arc volumetric modulated arc therapy (VMAT) were selected. Forty gray in 5 fractions were prescribed to cover 95% of the prostate planning target volume (PTV). To replan by 4π therapy, a column generation method was used to optimize beam orientations and fluence. A total of 30 beams were selected for each patient. RESULTS: Both planning methods provided adequate PTV coverage. Compared against VMAT plans, the 4π plan reduced the rectum V50%, V80%, V90%, D1cc, and the penile bulb maximum doses by 50%, 28%, 19% 11%, and 9% (P < .005), respectively, and the mean body dose was reduced from 2.07 Gy to 1.75 Gy (P = .0001). The bladder dose was only slightly reduced. CONCLUSIONS: By optimizing beam angles and fluences in the noncoplanar solution space, superior prostate treatment plan quality was achieved compared against state of the art VMAT plans. The dosimetric potential for 4π therapy is established on an existing C-arm linac platform.
PURPOSE: Significant dosimetric improvement for radiation therapy using optimized noncoplanar fields has been previously demonstrated. The purpose here is to study the feasibility of optimized robotic noncoplanar radiation therapy, termed 4π therapy, for prostate cancer treatments on a conventional C-arm linac. METHODS AND MATERIALS: Twelve low-risk prostate cancerpatients previously treated by 2-arc volumetric modulated arc therapy (VMAT) were selected. Forty gray in 5 fractions were prescribed to cover 95% of the prostate planning target volume (PTV). To replan by 4π therapy, a column generation method was used to optimize beam orientations and fluence. A total of 30 beams were selected for each patient. RESULTS: Both planning methods provided adequate PTV coverage. Compared against VMAT plans, the 4π plan reduced the rectum V50%, V80%, V90%, D1cc, and the penile bulb maximum doses by 50%, 28%, 19% 11%, and 9% (P < .005), respectively, and the mean body dose was reduced from 2.07 Gy to 1.75 Gy (P = .0001). The bladder dose was only slightly reduced. CONCLUSIONS: By optimizing beam angles and fluences in the noncoplanar solution space, superior prostate treatment plan quality was achieved compared against state of the art VMAT plans. The dosimetric potential for 4π therapy is established on an existing C-arm linac platform.
Authors: Dan Nguyen; Dan Ruan; Daniel O'Connor; Kaley Woods; Daniel A Low; Salime Boucher; Ke Sheng Journal: Med Phys Date: 2016-02 Impact factor: 4.071
Authors: Vyacheslav L Murzin; Kaley Woods; Vitali Moiseenko; Roshan Karunamuni; Kathryn R Tringale; Tyler M Seibert; Michael J Connor; Daniel R Simpson; Ke Sheng; Jona A Hattangadi-Gluth Journal: Radiother Oncol Date: 2018-03-05 Impact factor: 6.280
Authors: S V Kutsaev; R Agustsson; A Arodzero; R Berry; A Bezhanov; S Boucher; O Chimalpopoca; A Diego; L Faillace; D Gavryushkin; M Harrison; J J Hartzell; J McNevin; M Ruelas; A Yu Smirnov; A Verma; K Woods Journal: Radiat Phys Chem Oxf Engl 1993 Date: 2021-04-11 Impact factor: 2.776
Authors: Dan Nguyen; Jean-Claude M Rwigema; Victoria Y Yu; Tania Kaprealian; Patrick Kupelian; Michael Selch; Percy Lee; Daniel A Low; Ke Sheng Journal: Radiat Oncol Date: 2014-11-07 Impact factor: 3.481